Bioelectronics Corp (BIEL)

[Imagine48]

********Non Opioid Pain Managment Company ( Market Cap (423M) -Vs Biel (80M)*********

Read https://www.caratherapeutics.com/therapeutic-focus/chronic-pain/

Great Stats re Market Opportunity for Pain Management Solutions. Cara outlines it approach for pain management. Whereas Biel has actipatch approach but Cara talk about "Novel Analgesic" approach.

However CARA has not yet got FDA approval for the product, is not selling products or has not got UK government support via NHS to provide it for patients. But the market cap is 423 Million.

Biel has FDA approval , selling products, is support by NHS and has sales ramping up all over the world and yet is valued at less than 20% of CARA. The only difference is a Nasdaq listing.

Clear Deduction: Biel is an underexposed solution to Chronic pain and will trade will north of 1 cent very soon.